Indication: Tukysa, a kinase inhibitor

Tuksya is a kinase inhibitor recommended in combination with Trastuzumab and Capecitabine for treating adult patients with advanced unresectable or metastatic HER2-positive breast cancer, including patients with brain metastases who received one or more prior anti-HER2-based regimens in the metastatic setting and in combination with Trastuzumab for the treatment of adult patients with RAS wild-type HER2-positive […]

Overview Breast cancer, including patients with brain metastases.

As per the the Duke Center for Brain and Spine Metastases studies, Breast cancer is the most common cancer in women, with 276, 480 new cases predicted for the year 2020 in the United States alone.1 It is also the second most common cause of brain metastases (BrM), with different reports indicating variable 10% to 30% […]

Indian Pharma Network helps in accessing new products in India. These products are launched and approved recently in USA or Europe but yet to be approved in India. We help in accessing these new launches through named patient import.

Quick Links
About Us

Indian Pharma Network facilitates patients connecting with genuine pharmaceutical suppliers, wholesalers and dealers.

Indian Pharma Network.
info@indianpharmanetwork.in
Corporate Office
Indian Pharma Network.
905 – 9th Floor, I-Thum Business Park,
Tower A, Plot no. A-40, Unit no. 5,
Sector-62, Noida 201301,
info@indianpharmanetwork.in

  • +91 9310090915